Natural history of hepatic metastases from colorectal cancer - Pathobiological pathways with clinical significance

World Journal of Gastroenterology

Volumn 20, Issue 14, 2014, Pages 3719-3737

  Paschos, Konstantinos A ^a,b   Majeed, Ali W ^a   Bird, Nigel C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b General Hospital of Dramas   (Greece)

Author keywords

Colorectal cancer; Liver metastasis; Liver sinusoids; Metastatic cascade; Neovascularization

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GELATINASE A; GELATINASE B; GRANZYME; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE INHIBITOR; PERFORIN; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; PROTEIN P53; SCATTER FACTOR; SELECTIN; SYNDECAN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3; CADHERIN; CELL ADHESION MOLECULE; MATRIX METALLOPROTEINASE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE ARREST; CELL INTERACTION; CELL TYPE; COLORECTAL CANCER; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; EXTRAVASATION; FIBROBLAST; GENE MUTATION; HUMAN; KUPFFER CELL; LIVER METASTASIS; LIVER SINUSOID; LYMPHANGIOGENESIS; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PATHOLOGY; PIT CELL; SIGNAL TRANSDUCTION; STELLATE CELL; STROMA CELL; TUMOR INVASION; COLORECTAL TUMOR; CYTOLOGY; LIVER; LIVER TUMOR; METABOLISM; METASTASIS; MUTATION; NEOVASCULARIZATION (PATHOLOGY); SECONDARY; TREATMENT OUTCOME;

APOPTOSIS; CADHERINS; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; HEPATIC STELLATE CELLS; HUMANS; KUPFFER CELLS; LIVER; LIVER NEOPLASMS; MATRIX METALLOPROTEINASES; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; TREATMENT OUTCOME;

EID: 84898417231     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i14.3719     Document Type: Article

References (194)

1. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-292PMID: 22000009 DOI: 10.1016/j.cell.2011.09.024]
2. Ghobrial IM. Myeloma as a model for the process of metastasis: implications for therapy. Blood 2012; 120: 20-30PMID: 22535658 DOI: 10.1182/blood-2012-01-379024]
3. Kumar S, Weaver VM. Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 2009; 28: 113-127PMID: 19153673 DOI: 10.1007/s10555-008-9173-4]
4. Weinberg R. The biology of cancer. 1st ed. Taylor & Francis Group: Garland Science, 2007
5. Rejniak KA. Investigating dynamical deformations of tumor cells in circulation: predictions from a theoretical model. Front Oncol 2012; 2: 111PMID: 23024961 DOI: 10.3389/ fonc.2012.00111]
6. Chong HC, Tan CK, Huang RL, Tan NS. Matricellular proteins: a sticky affair with cancers. J Oncol 2012; 2012: 351089PMID: 22481923 DOI: 10.1155/2012/351089]
7. Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E, Franchi G, Morenghi E, Laghi L, Gennari L, Roncalli M. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer 2006; 95: 1101-1107PMID: 16969349 DOI: 10.1038/sj.bjc.6603337]
8. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-458PMID: 12778135 DOI: 10.1038/nrc.1098]
9. Nakao K, Shibusawa M, Ishihara A, Yoshizawa H, Tsunoda A, Kusano M, Kurose A, Makita T, Sasaki K. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer 2001; 91: 721-726PMID: 11241239]
10. Aragane H, Sakakura C, Nakanishi M, Yasuoka R, Fujita Y, Taniguchi H, Hagiwara A, Yamaguchi T, Abe T, Inazawa J, Yamagishi H. Chromosomal aberrations in colorectal cancers and liver metastases analyzed by comparative genomic hybridization. Int J Cancer 2001; 94: 623-629PMID: 11745455 DOI: 10.1002/ijc.1522]
11. Athanassiadou P, Grapsa D. Recent advances in the detection of bone marrow micrometastases: A promising area for research or just another false hope? A review of the literature. Cancer Metastasis Rev 2006; 25: 507-519PMID: 17160555 DOI: 10.1007/s10555-006-9030-2]
12. Pelkey TJ, Frierson HF, Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996; 42: 1369-1381PMID: 8787692]
13. Garborg K, Holme Ø, Løberg M, Kalager M, Adami HO, Bretthauer M. Current status of screening for colorectal cancer. Ann Oncol 2013; 24: 1963-1972PMID: 23619033 DOI: 10.1093/annonc/mdt157]
14. Slesser AA, Georgiou P, Brown G, Mudan S, Goldin R, Tekkis P. The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review. Clin Exp Metastasis 2013; 30: 457-470PMID: 23180209 DOI: 10.1007/s10585-012-9551-8]
15. Ballinger AB, Anggiansah C. Colorectal cancer. BMJ 2007; 335: 715-718PMID: 17916855 DOI: 10.1136/bmj.39321.527384. BE]
16. Jänne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med 2000; 342: 1960-1968PMID: 10874065 DOI: 10.1056/NEJM200006293422606]
17. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-793PMID: 16804544 DOI: 10.1038/ng1834]
18. Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology 2010; 138: 2059-2072PMID: 20420946 DOI: 10.1053/j.gastro.2009.12.065]
19. Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res 2012; 5: 19-27PMID: 22574233]
20. Droujinine IA, Eckert MA, Zhao W. To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells. Oncotarget 2013; 4: 651-664PMID: 23744479]
21. Yoo J, Perez CE, Nie W, Sinnett-Smith J, Rozengurt E. TNFalpha and LPA promote synergistic expression of COX-2 in human colonic myofibroblasts: role of LPA-mediated transactivation of upregulated EGFR. BMC Gastroenterol 2013; 13: 90PMID: 23688423 DOI: 10.1186/1471-230X-13-90]
22. Peddareddigari VG, Wang D, Dubois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron 2010; 3: 149-166PMID: 21209781 DOI: 10.1007/ s12307-010-0038-3]
23. Quante M, Varga J, Wang TC, Greten FR. The gastrointestinal tumor microenvironment. Gastroenterology 2013; 145: 63-78PMID: 23583733 DOI: 10.1053/j.gastro.2013.03.052]
24. Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, Alison MR, Wright NA. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004; 64: 8492-8495PMID: 15574751 DOI: 10.1158/0008-5472.CAN-04-1708]
25. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D. Carcinomaassociated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008; 68: 4331-4339PMID: 18519693 DOI: 10.1158/0008-5472.CAN-08-0943]
26. Shimoda M, Mellody KT, Orimo A. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 2010; 21: 19-25PMID: 19857592 DOI: 10.1016/j.semcdb.2009.10.002]
27. Gout S, Huot J. Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 2008; 1: 69-83PMID: 19308686 DOI: 10.1007/s12307-008-0007-2]
28. Zhu Y, Yin WL, Ba YF, Tian L, Gu ZQ, Zhang MS, Zhong CN. Transforming growth factor-1 promotes the transcriptional activation of plasminogen activator inhibitor type 1 in carcinoma-associated fibroblasts. Mol Med Rep 2012; 6: 1001-1005PMID: 22895748]
29. Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH. Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev 2008; 34: 122-136PMID: 18162327 DOI: 10.1016/ j.ctrv.2007.10.005]
30. Dimova EY, Kietzmann T. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thromb Haemost 2008; 100: 992-1006PMID: 19132222 DOI: 10.1160/ TH08-07-0490]
31. Berdiel-Acer M, Bohem ME, López-Doriga A, Vidal A, Salazar R, Martínez-Iniesta M, Santos C, Sanjuan X, Villanueva A, Molleví DG. Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death. Neoplasia 2011; 13: 931-946 PMID: 22028619 DOI: 10.1593/neo.11706]
32. Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology 2013; 218: 1402-1410PMID: 23891329 DOI: 10.1016/j.imbio.2013.06.003]
33. Kruse J, von Bernstorff W, Evert K, Albers N, Hadlich S, Hagemann S, Günther C, van Rooijen N, Heidecke CD, Partecke LI. Macrophages promote tumour growth and liver metastasis in an orthotopic syngeneic mouse model of colon cancer. Int J Colorectal Dis 2013; 28: 1337-1349 PMID:23657400 DOI: 10.1007/s00384-013-1703-z]
34. Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH, Wang XZ, Zhao YW, Wei YQ. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One 2012; 7: e50946PMID: 23284651 DOI: 10.1371/journal.pone.0050946]
35. Rudmik LR, Magliocco AM. Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol 2005; 92: 347-359PMID: 16299807 DOI: 10.1002/jso.20393]
36. Pavlidis ET, Pavlidis TE. Role of bevacizumab in colorectal cancer growth and its adverse effects: a review. World J Gastroenterol 2013; 19: 5051-5060PMID: 23964138 DOI: 10.3748/wjg.v19.i31.5051]
37. Martinelli E, Troiani T, Morgillo F, Orditura M, De Vita F, Belli G, Ciardiello F. Emerging VEGF-receptor inhibitors for colorectal cancer. Expert Opin Emerg Drugs 2013; 18: 25-37PMID: 23216053 DOI: 10.1517/14728214.2013.749856]
38. Popovic ZV, Sandhoff R, Sijmonsma TP, Kaden S, Jennemann R, Kiss E, Tone E, Autschbach F, Platt N, Malle E, Gröne HJ. Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity. J Immunol 2007; 179: 6770-6782PMID: 17982067]
39. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353: 2654-2666PMID: 16371631 DOI: 10.1056/NEJMoa051424]
40. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964PMID: 17008531 DOI: 10.1126/science.1129139]
41. Correale P, Rotundo MS, Botta C, Del Vecchio MT, Tassone P, Tagliaferri P. Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer. Oncoimmunology 2012; 1: 531-532PMID: 22754775 DOI: 10.4161/onci.19404]
42. de Miranda NF, Goudkade D, Jordanova ES, Tops CM, Hes FJ, Vasen HF, van Wezel T, Morreau H. Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases. Clin Cancer Res 2012; 18: 1237-1245 PMID: 22261803 DOI: 10.1158/1078-0432.CCR-11-1997]
43. Liu K. Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer. World J Gastrointest Oncol 2010; 2: 399-406PMID:21160903 DOI: 10.4251/wjgo.v2.i11.399]
44. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184: 1075-1082PMID: 9064324 DOI: 10.1084/jem.184.3.1075]
45. Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O'Byrne KJ, Giaccia AJ, KoongAC. Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 2005; 23: 8932-8941PMID:16219933 DOI: 10.1200/JCO.2005.02.0206]
46. Lu B, Finn OJ. T-cell death and cancer immune tolerance. Cell Death Differ 2008; 15: 70-79PMID: 18007660 DOI: 10.1038/sj.cdd.4402274]
47. Shurin MR, Shurin GV, Lokshin A, Yurkovetsky ZR, Gutkin DW, Chatta G, Zhong H, Han B, Ferris RL. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev 2006; 25: 333-356PMID: 17029028 DOI: 10.1007/ s10555-006-9010-6]
48. Guven Maiorov E, Keskin O, Gursoy A, Nussinov R. The structural network of inflammation and cancer: merits and challenges. Semin Cancer Biol 2013; 23: 243-251PMID: 23712403 DOI: 10.1016/j.semcancer.2013.05.003]
49. Beaty BT, Sharma VP, Bravo-Cordero JJ, Simpson MA, Eddy RJ, Koleske AJ, Condeelis J. β1 integrin regulates Arg to promote invadopodial maturation and matrix degradation. Mol Biol Cell 2013; 24: 1661-1675, S1-11PMID: 23552693 DOI: 10.1091/mbc.E12-12-0908]
50. Pöschl E, Schlötzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 2004; 131: 1619-1628PMID: 14998921 DOI: 10.1242/dev.01037]
51. Tanner K. Regulation of the basement membrane by epithelia generated forces. Phys Biol 2012; 9: 065003PMID: 23196920 DOI: 10.1088/1478-3975/9/6/065003]
52. Peranzoni E, Rivas-Caicedo A, Bougherara H, Salmon H, Donnadieu E. Positive and negative influence of the matrix architecture on antitumor immune surveillance. Cell Mol Life Sci 2013; 70: 4431-4448PMID: 23649148 DOI: 10.1007/ s00018-013-1339-8]
53. Zhang YY, Chen B, Ding YQ. Metastasis-associated factors facilitating the progression of colorectal cancer. Asian Pac J Cancer Prev 2012; 13: 2437-2444PMID: 22938401 DOI: 10.7314/APJCP.2012.13.6.2437]
54. Zapatka M, Zboralski D, Radacz Y, Böckmann M, Arnold C, Schöneck A, Hoppe S, Tannapfel A, Schmiegel W, Simon- Assmann P, Schwarte-Waldhoff I. Basement membrane component laminin-5 is a target of the tumor suppressor Smad4. Oncogene 2007; 26: 1417-1427PMID: 16953227 DOI: 10.1038/sj.onc.1209918]
55. Mizutani K, Kawano S, Minami A, Waseda M, Ikeda W, Takai Y. Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomes. J Biol Chem 2011; 286: 36667-36676 PMID:21880726 DOI: 10.1074/jbc.M110.200535]
56. Müller-Edenborn B, Roth-Zgraggen B, Bartnicka K, Borgeat A, Hoos A, Borsig L, Beck-Schimmer B. Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9. Anesthesiology 2012; 117: 293-301PMID: 22739763 DOI: 10.1097/ ALN.0b013e3182605df1]
57. Kryczka J, Stasiak M, Dziki L, Mik M, Dziki A, Cierniewski C. Matrix metalloproteinase-2 cleavage of the β1 integrin ectodomain facilitates colon cancer cell motility. J Biol Chem 2012; 287: 36556-36566 PMID:22898815 DOI: 10.1074/jbc. M112.384909]
58. Stenzinger A, Wittschieber D, von Winterfeld M, Goeppert B, Kamphues C, Weichert W, Dietel M, Rabien A, Klauschen F. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer. Hum Pathol 2012; 43: 1471-1481PMID: 22417846 DOI: 10.1016/ j.humpath.2011.10.023]
59. Todosi AM, Gavrilescu MM, Aniţei GM, Filip B, Scripcariu V. Colon cancer at the molecular level--usefulness of epithelial- mesenchymal transition analysis. Rev Med Chir Soc Med Nat Iasi 2012; 116: 1106-1111PMID: 23700897]
60. Zhu QC, Gao RY, Wu W, Qin HL. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev 2013; 14: 2689-2698PMID: 23803016 DOI: 10.7314/APJCP.2013.14.5.2689]
61. Narita T, Kawakami-Kimura N, Kasai Y, Hosono J, Nakashio T, Matsuura N, Sato M, Kannagi R. Induction of E-selectin expression on vascular endothelium by digestive system cancer cells. J Gastroenterol 1996; 31: 299-301 PMID:8680556 DOI: 10.1007/BF02389535]
62. Matsuo Y, Sawai H, Ma J, Xu D, Ochi N, Yasuda A, Takahashi H, Funahashi H, Takeyama H. IL-1alpha secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1alpha release and tumor cells' potential for liver metastasis. J Surg Oncol 2009; 99: 361-367PMID: 19204921 DOI: 10.1002/jso.21245]
63. Borthwick LA, Gardner A, De Soyza A, Mann DA, Fisher AJ. Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways. Cancer Microenviron 2012; 5: 45-57PMID: 21792635 DOI: 10.1007/s12307-011-0080-9]
64. Fuxe J, Vincent T, Garcia de Herreros A. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010; 9: 2363-2374PMID: 20519943 DOI: 10.4161/ cc.9.12.12050]
65. Katsuno Y, Lamouille S, Derynck R. TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 2013; 25: 76-84PMID:23197193 DOI: 10.1097/CCO.0b013e32835b6371]
66. Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 2008; 283: 33437-33446PMID: 18832382 DOI: 10.1074/jbc.M802016200]
67. Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, Fang JY. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem 2012; 287: 5819-5832PMID: 22205702 DOI: 10.1074/ jbc.M111.295964]
68. Stoops SL, Pearson AS, Weaver C, Waterson AG, Days E, Farmer C, Brady S, Weaver CD, Beauchamp RD, Lindsley CW. Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells. ACS Chem Biol 2011; 6: 452-465PMID: 21241068 DOI: 10.1021/cb100305h]
69. Qi J, Zhu YQ. Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer. Curr Drug Targets 2008; 9: 548-557PMID: 18673240 DOI: 10.2174/138945008784911769]
70. Avizienyte E, Fincham VJ, Brunton VG, Frame MC. Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition. Mol Biol Cell 2004; 15: 2794-2803PMID: 15075377 DOI: 10.1091/mbc. E03-12-0879]
71. Avizienyte E, Brunton VG, Fincham VJ, Frame MC. The SRC-induced mesenchymal state in late-stage colon cancer cells. Cells Tissues Organs 2005; 179: 73-80PMID: 15942195 DOI: 10.1159/000084511]
72. Minard ME, Ellis LM, Gallick GE. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis 2006; 23: 301-313PMID: 17086355 DOI: 10.1007/s10585-006-9040-z]
73. Bellovin DI, Simpson KJ, Danilov T, Maynard E, Rimm DL, Oettgen P, Mercurio AM. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 2006; 25: 6959-6967PMID: 16715134 DOI: 10.1038/sj.onc.1209682]
74. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674PMID: 9109485 DOI: 10.1038/386671a0]
75. Fukuda R, Kelly B, Semenza GL. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res 2003; 63: 2330-2334PMID: 12727858]
76. Finetti F, Donnini S, Giachetti A, Morbidelli L, Ziche M. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. Circ Res 2009; 105: 657-666PMID: 19713533 DOI: 10.1161/CIRCRESAHA.109.203760]
77. Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med 2012; 2: a006627PMID: 22553494 DOI: 10.1101/cshperspect.a006627]
78. Owen JL, Mohamadzadeh M. Macrophages and chemokines as mediators of angiogenesis. Front Physiol 2013; 4: 159PMID: 23847541 DOI: 10.3389/fphys.2013.00159]
79. Choi HJ, Hyun MS, Jung GJ, Kim SS, Hong SH. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 1998; 55: 575-581PMID: 9778626 DOI: 10.1159/000011915]
80. Chen CN, Cheng YM, Liang JT, Lee PH, Hsieh FJ, Yuan RH, Wang SM, Chang MF, Chang KJ. Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients. Cancer Res 2000; 60: 2892-2897PMID: 10850434]
81. Leen E, Goldberg JA, Angerson WJ, McArdle CS. Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 2000; 355: 34-37PMID: 10615889 DOI: 10.1016/S0140-6736(99)06322-9]
82. Goh V, Padhani AR, Rasheed S. Functional imaging of colorectal cancer angiogenesis. Lancet Oncol 2007; 8: 245-255PMID: 17329195 DOI: 10.1016/S1470-2045(07)70075-X]
83. Royston D, Jackson DG. Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 2009; 217: 608-619PMID: 19253334 DOI: 10.1002/path.2517]
84. Yoon CM, Hong BS, Moon HG, Lim S, Suh PG, Kim YK, Chae CB, Gho YS. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. Blood 2008; 112: 1129-1138PMID: 18541717 DOI: 10.1182/blood-2007-11-125203]
85. Nagahashi M, Ramachandran S, Rashid OM, Takabe K. Lymphangiogenesis: a new player in cancer progression. World J Gastroenterol 2010; 16: 4003-4012PMID: 20731013 DOI: 10.3748/wjg.v16.i32.4003]
86. Anelli V, Gault CR, Snider AJ, Obeid LM. Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. FASEB J 2010; 24: 2727-2738PMID: 20335228 DOI: 10.1096/fj.09-150540]
87. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF. Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 2006; 19: 1317-1323PMID: 16799477 DOI: 10.1038/modpathol.3800651]
88. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005; 438: 946-953PMID: 16355212 DOI: 10.1038/nature04480]
89. Du B, Yang ZY, Zhong XY, Fang M, Yan YR, Qi GL, Pan YL, Zhou XL. Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World J Gastroenterol 2011; 17: 1219-1226PMID: 21448429 DOI: 10.3748/wjg.v17.i9.1219]
90. Langheinrich MC, Schellerer V, Perrakis A, Lohmüller C, Schildberg C, Naschberger E, Stürzl M, Hohenberger W, Croner RS. Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract. Int J Clin Exp Pathol 2012; 5: 614-623PMID: 22977656]
91. Sundlisaeter E, Dicko A, Sakariassen PØ, Sondenaa K, Enger PØ, Bjerkvig R. Lymphangiogenesis in colorectal cancer-- prognostic and therapeutic aspects. Int J Cancer 2007; 121: 1401-1409PMID: 17640040 DOI: 10.1002/ijc.22996]
92. He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P, Salven P, Alitalo K. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 2004; 64: 3737-3740PMID: 15172976 DOI: 10.1158/0008-5472.CAN-04-0088]
93. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest 2005; 115: 2316-2319PMID: 16138185 DOI: 10.1172/JCI26354]
94. Meijer J, Zeelenberg IS, Sipos B, Roos E. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. Cancer Res 2006; 66: 9576-9582PMID: 17018614 DOI: 10.1158/0008-5472. CAN-06-1507]
95. Gomes FG, Nedel F, Alves AM, Nör JE, Tarquinio SB. Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms. Life Sci 2013; 92: 101-107PMID: 23178150 DOI: 10.1016/j.lfs.2012.10.008]
96. Sonoshita M, Aoki M, Fuwa H, Aoki K, Hosogi H, Sakai Y, Hashida H, Takabayashi A, Sasaki M, Robine S, Itoh K, Yoshioka K, Kakizaki F, Kitamura T, Oshima M, Taketo MM. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell 2011; 19: 125-137PMID: 21251616 DOI: 10.1016/j.ccr.2010.11.008]
97. Sier CF, Vloedgraven HJ, Griffioen G, Ganesh S, Nagengast FM, Lamers CB, Verspaget HW. Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis. Br J Cancer 1995; 71: 393-396PMID: 7841059 DOI: 10.1038/bjc.1995.80]
98. Ploplis VA, Tipton H, Menchen H, Castellino FJ. A urokinase- type plasminogen activator deficiency diminishes the frequency of intestinal adenomas in ApcMin/+ mice. J Pathol 2007; 213: 266-274PMID: 17893885 DOI: 10.1002/ path.2236]
99. Hildenbrand R, Gandhari M, Stroebel P, Marx A, Allgayer H, Arens N. The urokinase-system--role of cell proliferation and apoptosis. Histol Histopathol 2008; 23: 227-236PMID: 17999379]
100. Kwaan HC, McMahon B. The role of plasminogen-plasmin system in cancer. Cancer Treat Res 2009; 148: 43-66PMID: 19377918 DOI: 10.1007/978-0-387-79962-9_4]
101. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, Liu ET, Cance WG. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995; 55: 2752-2755PMID: 7796399]
102. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006; 6: 449-458PMID: 16723991 DOI: 10.1038/nrc1886]
103. Karkkainen MJ, Mäkinen T, Alitalo K. Lymphatic endothelium: a new frontier of metastasis research. Nat Cell Biol 2002; 4: E2-E5PMID: 11780131 DOI: 10.1038/ncb0102-e2]
104. Shin MK, Kim SK, Jung H. Integration of intra- and extravasation in one cell-based microfluidic chip for the study of cancer metastasis. Lab Chip 2011; 11: 3880-3887PMID: 21975823 DOI: 10.1039/c1lc20671k]
105. Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 2007; 104: 17406-17411PMID: 17954920 DOI: 10.1073/ pnas.0703446104]
106. Yamauchi K, Yang M, Jiang P, Yamamoto N, Xu M, Amoh Y, Tsuji K, Bouvet M, Tsuchiya H, Tomita K, Moossa AR, Hoffman RM. Real-time in vivo dual-color imaging of intracapillary cancer cell and nucleus deformation and migration. Cancer Res 2005; 65: 4246-4252PMID: 15899816 DOI: 10.1158/0008-5472.CAN-05-0069]
107. Chow KH, Factor RE, Ullman KS. The nuclear envelope environment and its cancer connections. Nat Rev Cancer 2012; 12: 196-209PMID: 22337151 DOI: 10.1038/nrc3219]
108. Placke T, Kopp HG, Salih HR. The wolf in sheep's clothing: Platelet-derived "pseudo self" impairs cancer cell "missing self" recognition by NK cells. Oncoimmunology 2012; 1: 557-559PMID: 22754786 DOI: 10.4161/onci.19367]
109. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009; 461: 109-113PMID: 19693011 DOI: 10.1038/nature08268]
110. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004; 430: 1034-1039PMID: 15329723 DOI: 10.1038/nature02765]
111. Samak R, Israël L. Extraction and identification of circulating immune complexes from the serum of cancer patient by affinity chromatography followed by high pressure steric exclusion chromatography. Demonstration of their effect on the mitogenesis of normal lymphocytes]. Ann Med Interne (Paris) 1982; 133: 362-366PMID: 7149514]
112. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-252PMID: 19279573 DOI: 10.1038/nrc2618]
113. Vekemans K, Braet F. Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis. World J Gastroenterol 2005; 11: 5095-5102PMID: 16127736]
114. Smedsrød B, Le Couteur D, Ikejima K, Jaeschke H, Kawada N, Naito M, Knolle P, Nagy L, Senoo H, Vidal-Vanaclocha F, Yamaguchi N. Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium. Liver Int 2009; 29: 490-501PMID: 19210626 DOI: 10.1111/ j.1478-3231.2009.01979.x]
115. Timmers M, Vekemans K, Vermijlen D, Asosingh K, Kuppen P, Bouwens L, Wisse E, Braet F. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 2004; 112: 793-802PMID: 15386374 DOI: 10.1002/ijc.20481]
116. Enns A, Gassmann P, Schlüter K, Korb T, Spiegel HU, Senninger N, Haier J. Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg 2004; 8: 1049-159; discussion 1060PMID: 15585393 DOI: 10.1016/j.gassur.2004.08.016]
117. Wisse E, De Zanger RB, Charels K, Van Der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 1985; 5: 683-692PMID: 3926620 DOI: 10.1002/hep.1840050427]
118. Braet F, Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 2002; 1: 1PMID: 12437787 DOI: 10.1186/1476-5926-1-1]
119. Jansen S, Andries M, Vekemans K, Vanbilloen H, Verbruggen A, Bollen M. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett 2009; 284: 216-221PMID: 19482419 DOI: 10.1016/j.canlet.2009.04.029]
120. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Tomiya T, Tejima K, Nishikawa T, Arai M, Yanase M, Aoki J, Arai H, Omata M, Fujiwara K, Yatomi Y. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life Sci 2007; 81: 1009-1015PMID: 17850827 DOI: 10.1016/ j.lfs.2007.08.013]
121. Laferriere J, Houle F, Taher MM, Valerie K, Huot J. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem 2001; 276: 33762-33772PMID: 11448946 DOI: 10.1074/jbc.M008564200]
122. Gangopadhyay A, Lazure DA, Thomas P. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 1998; 16: 703-712PMID: 10211983]
123. Jacobs F, Wisse E, De Geest B. The role of liver sinusoidal cells in hepatocyte-directed gene transfer. Am J Pathol 2010; 176: 14-21PMID: 19948827 DOI: 10.2353/ajpath.2010.090136]
124. Bouwens L, De Bleser P, Vanderkerken K, Geerts B, Wisse E. Liver cell heterogeneity: functions of non-parenchymal cells. Enzyme 1992; 46: 155-168PMID: 1289080]
125. Laskin DL. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 1990; 10: 293-304PMID: 2281337 DOI: 10.1055/s-2008-1040485]
126. Laskin DL, Weinberger B, Laskin JD. Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 2001; 70: 163-170PMID: 11493607]
127. Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 2007; 96: 2-15PMID: 17122412 DOI: 10.1093/toxsci/kfl173]
128. Tu Z, Bozorgzadeh A, Pierce RH, Kurtis J, Crispe IN, Orloff MS. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med 2008; 205: 233-244PMID: 18195076 DOI: 10.1084/jem.20072195]
129. Gardner CR, Wasserman AJ, Laskin DL. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res 1987; 47: 6686-6691PMID: 3119198]
130. Bayón LG, Izquierdo MA, Sirovich I, van Rooijen N, Beelen RH, Meijer S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 1996; 23: 1224-1231PMID: 8621157 DOI: 10.1053/jhep.1996.v23.pm0008621157]
131. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-326PMID: 3543052 DOI: 10.1172/JCI112815]
132. Decker T, Lohmann-Matthes ML, Karck U, Peters T, Decker K. Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages. J Leukoc Biol 1989; 45: 139-146PMID: 2783725]
133. Gardner CR, Wasserman AJ, Laskin DL. Liver macrophagemediated cytotoxicity toward mastocytoma cells involves phagocytosis of tumor targets. Hepatology 1991; 14: 318-324PMID: 1907256 DOI: 10.1002/hep.1840140219]
134. Seki S, Habu Y, Kawamura T, Takeda K, Dobashi H, Ohkawa T, Hiraide H. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev 2000; 174: 35-46 PMID: 10807505 DOI: 10.1034/j.1600-0528.2002.017404.x]
135. Su W, Kitagawa T, Ito T, Oyama T, Lee CM, Kim YK, Matsuda H. Antitumor effect to IL-12 administration into the portal vein on murine liver metastasis. J Hepatobiliary Pancreat Surg 2002; 9: 503-510PMID: 12483274 DOI: 10.1007/ s005340200063]
136. Luo Y, Ohmori H, Fujii K, Moriwaka Y, Sasahira T, Kurihara M, Tatsumoto N, Sasaki T, Yamashita Y, Kuniyasu H. HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer. Eur J Cancer 2010; 46: 791-799PMID: 20018503 DOI: 10.1016/j.ejca.2009.11.011]
137. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26: 1175-1186PMID: 17105582 DOI: 10.1111/j.1478-3231.2006.01342.x]
138. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 1999; 30: 48-60PMID: 9927150 DOI: 10.1016/S0168-8278(99)80007-5]
139. Gorden DL, Fingleton B, Crawford HC, Jansen DE, Lepage M, Matrisian LM. Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment. Int J Cancer 2007; 121: 495-500PMID: 17417772 DOI: 10.1002/ijc.22594]
140. Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: A review. J Surg Oncol 2006; 94: 68-80PMID: 16788948 DOI: 10.1002/jso.20558]
141. Thomas P, Hayashi H, Zimmer R, Forse RA. Regulation of cytokine production in carcinoembryonic antigen stimulated Kupffer cells by beta-2 adrenergic receptors: implications for hepatic metastasis. Cancer Lett 2004; 209: 251-257PMID: 15159029 DOI: 10.1016/j.canlet.2003.12.027]
142. Gangopadhyay A, Lazure DA, Kelly TM, Thomas P. Purification and analysis of an 80-kDa carcinoembryonic antigen-binding protein from Kupffer cells. Arch Biochem Biophys 1996; 328: 151-157PMID: 8638924 DOI: 10.1006/ abbi.1996.0155]
143. Gangopadhyay A, Lazure DA, Thomas P. Carcinoembryonic antigen induces signal transduction in Kupffer cells. Cancer Lett 1997; 118: 1-6PMID: 9310253 DOI: 10.1016/ S0304-3835(97)00216-4]
144. Aarons CB, Bajenova O, Andrews C, Heydrick S, Bushell KN, Reed KL, Thomas P, Becker JM, Stucchi AF. Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells. Clin Exp Metastasis 2007; 24: 201-209PMID: 17487559 DOI: 10.1007/s10585-007-9069-7]
145. Jessup JM, Ishii S, Mitzoi T, Edmiston KH, Shoji Y. Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells. Clin Exp Metastasis 1999; 17: 481-488PMID: 10763913]
146. Jessup JM, Samara R, Battle P, Laguinge LM. Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway. Clin Exp Metastasis 2004; 21: 709-717PMID: 16035616 DOI: 10.1007/s10585-004- 7705-z]
147. Khatib AM, Auguste P, Fallavollita L, Wang N, Samani A, Kontogiannea M, Meterissian S, Brodt P. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 2005; 167: 749-759PMID: 16127154 DOI: 10.1016/S0002-9440(10)62048-2]
148. Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A, Brodt P. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 2007; 170: 1781-1792PMID: 17456781 DOI: 10.2353/ajpath.2007.060886]
149. Minami S, Furui J, Kanematsu T. Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen. Cancer Res 2001; 61: 2732-2735PMID: 11289155]
150. van der Bij GJ, Oosterling SJ, Meijer S, Beelen RH, van Egmond M. Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth. Immunobiology 2005; 210: 259-265 PMID: 16164033 DOI: 10.1016/j.imbio.2005.05.020]
151. Schuurman B, Heuff G, Beelen RH, Meyer S. Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony-stimulating factor and interferon gamma. Cancer Immunol Immunother 1994; 39: 179-184PMID: 7923248]
152. Schuurman B, Koenen HJ, Beelen RH, Meyer S. Granulocyte macrophage colony stimulating factor pretreatment induces an increase of rat Kupffer cells with enhanced cytotoxicity in vitro and prevention of tumor outgrowth in vivo. Anticancer Drugs 1997; 8: 269-275PMID: 9095332 DOI: 10.1097/00001813-199703000-00008]
153. Rushfeldt C, Sveinbjørnsson B, Seljelid R, Smedsrød B. Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gammastimulated defense. J Surg Res 1999; 82: 209-215PMID: 10090831 DOI: 10.1006/jsre.1998.5532]
154. Sawitza I, Kordes C, Reister S, Häussinger D. The niche of stellate cells within rat liver. Hepatology 2009; 50: 1617-1624PMID: 19725107 DOI: 10.1002/hep.23184]
155. Maher JJ. Interactions between hepatic stellate cells and the immune system. Semin Liver Dis 2001; 21: 417-426PMID: 11586469 DOI: 10.1055/s-2001-17555]
156. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125-172PMID: 18195085 DOI: 10.1152/physrev.00013.2007]
157. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007; 26: 117-129PMID: 17239632 DOI: 10.1016/j.immuni.2006.11.011]
158. Winau F, Quack C, Darmoise A, Kaufmann SH. Starring stellate cells in liver immunology. Curr Opin Immunol 2008; 20: 68-74PMID: 18068343 DOI: 10.1016/j.coi.2007.10.006]
159. Brun P, Castagliuolo I, Pinzani M, Palù G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2005; 289: G571-G578PMID: 15860640 DOI: 10.1152/ajpgi.00537.2004]
160. March S, Graupera M, Rosa Sarrias M, Lozano F, Pizcueta P, Bosch J, Engel P. Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule. Am J Pathol 2007; 170: 176-187PMID: 17200192 DOI: 10.2353/ajpath.2007.051212]
161. Di Sario A, Baroni GS, Bendia E, D'Ambrosio L, Ridolfi F, Marileo JR, Jezequel AM, Benedetti A. Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. Am J Physiol 1997; 273: G39-G48PMID: 9252507]
162. Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, Vizzutti F, Anania FA, Milani S, Rombouts K, Laffi G, Pinzani M, Marra F. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005; 42: 1339-1348PMID: 16317688 DOI: 10.1002/hep.20965]
163. Qamar A, Sheikh SZ, Masud A, Jhandier MN, Inayat IB, Hakim W, Mehal WZ. In vitro and in vivo protection of stellate cells from apoptosis by leptin. Dig Dis Sci 2006; 51: 1697-1705PMID: 16957995 DOI: 10.1007/s10620-006-9244-8]
164. Faouzi S, Lepreux S, Bedin C, Dubuisson L, Balabaud C, Bioulac-Sage P, Desmoulière A, Rosenbaum J. Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest 1999; 79: 485-493PMID: 10212001]
165. Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, Friedman SL, Vidal-Vanaclocha F. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 2003; 37: 674-685PMID: 12601365 DOI: 10.1053/jhep.2003.50068]
166. Shimizu S, Yamada N, Sawada T, Ikeda K, Kawada N, Seki S, Kaneda K, Hirakawa K. In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells. Jpn J Cancer Res 2000; 91: 1285-1295PMID: 11123428 DOI: 10.1111/j.1349-7006.2000.tb00916.x]
167. Wirz W, Antoine M, Tag CG, Gressner AM, Korff T, Hellerbrand C, Kiefer P. Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation 2008; 76: 784-794PMID: 18177423 DOI: 10.1111/ j.1432-0436.2007.00260.x]
168. Nakatani K, Kaneda K, Seki S, Nakajima Y. Pit cells as liverassociated natural killer cells: morphology and function. Med Electron Microsc 2004; 37: 29-36PMID: 15057602 DOI: 10.1007/s00795-003-0229-9]
169. Luo DZ, Vermijlen D, Ahishali B, Triantis V, Plakoutsi G, Braet F, Vanderkerken K, Wisse E. On the cell biology of pit cells, the liver-specific NK cells. World J Gastroenterol 2000; 6: 1-11PMID: 11819514]
170. Timonen T, Helander TS. Natural killer cell-target cell interactions. Curr Opin Cell Biol 1997; 9: 667-673PMID: 9330870 DOI: 10.1016/S0955-0674(97)80120-2]
171. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 1994; 12: 735-773PMID: 8011296 DOI: 10.1146/annurev. immunol.12.1.735]
172. Luo D, Vanderkerken K, Bouwens L, Kuppen PJ, Baekeland M, Seynaeve C, Wisse E. The role of adhesion molecules in the recruitment of hepatic natural killer cells (pit cells) in rat liver. Hepatology 1996; 24: 1475-1480PMID: 8938183 DOI: 10.1002/hep.510240629]
173. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev 2006; 20: 123-137PMID: 16364519 DOI: 10.1016/j.blre.2005.10.001]
174. Vermijlen D, Luo D, Robaye B, Seynaeve C, Baekeland M, Wisse E. Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/ granzyme pathway. Hepatology 1999; 29: 51-56PMID: 9862849 DOI: 10.1002/hep.510290143]
175. Haier J, Nicolson GL. Tumor cell adhesion under hydrodynamic conditions of fluid flow. APMIS 2001; 109: 241-262PMID: 11469496 DOI: 10.1034/j.1600-0463.2001.d01-118.x]
176. Haier J, Nicolson GL. The role of tumor cell adhesion as an important factor in formation of distant colorectal metastasis. Dis Colon Rectum 2001; 44: 876-884PMID: 11391152 DOI: 10.1007/BF02234713]
177. Shimizu S, Yamada N, Sawada T, Ikeda K, Nakatani K, Seki S, Kaneda K, Hirakawa K. Ultrastructure of early phase hepatic metastasis of human colon carcinoma cells with special reference to desmosomal junctions with hepatocytes. Pathol Int 2000; 50: 953-959PMID: 11123761 DOI: 10.1046/ j.1440-1827.2000.01153.x]
178. Braet F, Nagatsuma K, Saito M, Soon L, Wisse E, Matsuura T. The hepatic sinusoidal endothelial lining and colorectal liver metastases. World J Gastroenterol 2007; 13: 821-825PMID: 17352008]
179. Hosch SB, Steffani KD, Scheunemann P, Izbicki JR. Micrometastases from HBP malignancies and metastatic cancer. J Hepatobiliary Pancreat Surg 2002; 9: 583-591PMID: 12541044 DOI: 10.1007/s005340200078]
180. Ikawa K, Terashima Y, Sasaki K, Tashiro S. Genetic detection of liver micrometastases that are undetectable histologically. J Surg Res 2002; 106: 124-130PMID: 12127817 DOI: 10.1006/jsre.2002.6459]
181. Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009; 9: 285-293PMID: 19308068 DOI: 10.1038/nrc2621]
182. Du L, Rao G, Wang H, Li B, Tian W, Cui J, He L, Laffin B, Tian X, Hao C, Liu H, Sun X, Zhu Y, Tang DG, Mehrpour M, Lu Y, Chen Q. CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer. Cancer Res 2013; 73: 2682-2694PMID: 23418321 DOI: 10.1158/0008-5472.CAN-12-3759]
183. Chen X, Wang Y, Xia H, Wang Q, Jiang X, Lin Z, Ma Y, Yang Y, Hu M. Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis. Mol Biol Rep 2012; 39: 6707-6714PMID: 22311018 DOI: 10.1007/s11033-012-1494-2]
184. Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, Hood L, Yuan Y, Lin B. Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One 2012; 7: e41335PMID: 22912670 DOI: 10.1371/journal.pone.0041335]
185. Belluco C, Mammano E, Petricoin E, Prevedello L, Calvert V, Liotta L, Nitti D, Lise M. Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis. Clin Chim Acta 2005; 357: 180-183PMID: 15921671 DOI: 10.1016/j.cccn.2005.03.024]
186. Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007; 7: 737-749PMID: 17891189 DOI: 10.1038/nrc2229]
187. Kuiper T, van den Broek FJ, van Eeden S, Fockens P, Dekker E. Feasibility and accuracy of confocal endomicroscopy in comparison with narrow-band imaging and chromoendoscopy for the differentiation of colorectal lesions. Am J Gastroenterol 2012; 107: 543-550PMID: 22433922 DOI: 10.1038/ajg.2012.14]
188. Dai F, Shu L, Bian Y, Wang Z, Yang Z, Chu W, Gao S. Safety of bevacizumab in treating metastatic colorectal cancer: a systematic review and meta-analysis of all randomized clinical trials. Clin Drug Investig 2013; 33: 779-788PMID: 23979925 DOI: 10.1007/s40261-013-0125-6]
189. Chong G, Bhatnagar A, Cunningham D, Cosgriff TM, Harper PG, Steward W, Bridgewater J, Moore M, Cassidy J, Coleman R, Coxon F, Redfern CH, Jones JJ, Hawkins R, Northfelt D, Sreedharan S, Valone F, Carmichael J. Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 antiidiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Ann Oncol 2006; 17: 437-442PMID: 16311275 DOI: 10.1093/annonc/mdj090]
190. Ganea E, Trifan M, Laslo AC, Putina G, Cristescu C. Matrix metalloproteinases: useful and deleterious. Biochem Soc Trans 2007; 35: 689-691PMID: 17635123]
191. Le Tourneau C, Faivre S, Raymond E. The role of integrins in colorectal cancer. Oncology (Williston Park) 2007; 21: 21-24PMID: 17927027]
192. Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 2013; 39: 74-88PMID: 23890065 DOI: 10.1016/j.immuni.2013.06.014]
193. Fujii SI, Shimizu K. Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune response. Oncoimmunology 2013; 2: e23432PMID: 23734303 DOI: 10.4161/onci.23432]
194. Smith CW. 3. Adhesion molecules and receptors. J Allergy Clin Immunol 2008; 121: S375-S39; quiz S414PMID: 18241685 DOI: 10.1016/j.jaci.2007.07.030]